Former senator JV Ejercito, during an online conference on..
The Food and Drug Administration (FDA) has given the nod to the use of Pfizer COVID-19 vaccine among 12 to 15-year-olds, the Department of Health (DOH) confirmed Tuesday, June 8.
Pfizer’s amended emergency use authorization (EUA) now states that the vaccines can be used for individuals aged 12 and above. Previously, the American-made jabs were allowed for the use of 16-year-olds and older.
Health Undersecretary Maria Rosario Vergeire noted, however, that the younger age group will not be vaccinated yet and the government will still follow the prioritization framework.
“While we welcome more vaccines that are approved for children and adolescents, due to limited vaccine supply, our vaccination strategy remains the same — prioritize the vulnerable and adhere to our prioritization framework,” Vergeire said.
She added that the vaccination of children and adolescents will be revisited once there is a stable supply of vaccines in the country.